Clinical trial
A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With…
NCT00441558 · Sprout Pharmaceuticals, Inc, Industry · Terminated
Key facts
| NCT number | NCT00441558 |
|---|---|
| Title | A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD). |
| Official title | Worldwide One-year Open-label Safety Study of Flibanserin in Women With HSDD |
| Lead sponsor | Sprout Pharmaceuticals, Inc, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sexual Dysfunctions, Psychological |
| Intervention type | Drug |
| Interventions | Flibanserin |
| Enrollment | 1,723 |
| Start date | Feb 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Mar 1, 2007 |
| Last update posted | Jun 13, 2014 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: